CCM
BMY icon

Catapult Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Catapult Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-100,000
Closed -$5.32M – 202
2013
Q4 		$5.32M Buy
+100,000
New +$5.09M 1.27% 21

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catapult Capital Management's BMY Position: Q3 2015 in Review

Catapult Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2015: 23,542 shares worth $1.39M. The stake represents 0.53% of the portfolio and ranks #73 among its holdings. This is a return to the name: Catapult Capital Management previously reported a position in BMY as recently as Q4 2013.

Catapult Capital Management first reported a position in BMY in Q4 2013 and has held it in 2 quarters since. The position peaked at $4.52M in Q4 2013. 1,454 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

  • Catapult Capital Management held 23,542 shares of Bristol-Myers Squibb worth $1.39M as of Q3 2015.
  • Bristol-Myers Squibb was a new Catapult Capital Management position in Q3 2015.
  • Bristol-Myers Squibb made up 0.53% of Catapult Capital Management's portfolio in Q3 2015, its #73 holding.
  • Catapult Capital Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 2 quarters since.
  • Catapult Capital Management's Bristol-Myers Squibb position peaked at $4.52M in Q4 2013.
  • 1,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.